Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Jan;43(1):118–121. doi: 10.1038/bjc.1981.19

Possible surface protein markers for breast cancer.

M Wildridge, G V Sherbet
PMCID: PMC2010487  PMID: 7459233

Full text

PDF
118

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowen J. G., Kulatilake A. E. A common marker for cancer cells? Br J Cancer. 1979 Nov;40(5):806–808. doi: 10.1038/bjc.1979.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bramwell M. E., Harris H. An abnormal membrane glycoprotein associated with malignancy in a wide range of different tumours. Proc R Soc Lond B Biol Sci. 1978 Apr 13;201(1142):87–106. doi: 10.1098/rspb.1978.0034. [DOI] [PubMed] [Google Scholar]
  3. Brunson K. W., Beattie G., Nicolsin G. L. Selection and altered properties of brain-colonising metastatic melanoma. Nature. 1978 Apr 6;272(5653):543–545. doi: 10.1038/272543a0. [DOI] [PubMed] [Google Scholar]
  4. Cove D. H., Woods K. L., Smith S. C., Burnett D., Leonard J., Grieve R. J., Howell A. Tumour markers in breast cancer. Br J Cancer. 1979 Nov;40(5):710–718. doi: 10.1038/bjc.1979.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Guy D., Latner A. L., Turner G. A. Radioiodination studies of tumour cell-surface proteins after different disaggregation procedures. Br J Cancer. 1977 Aug;36(2):166–172. doi: 10.1038/bjc.1977.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hynes R. O. Alteration of cell-surface proteins by viral transformation and by proteolysis. Proc Natl Acad Sci U S A. 1973 Nov;70(11):3170–3174. doi: 10.1073/pnas.70.11.3170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Price M. R., Stoddart R. W. A characteristic protein of the surfaces of neoplastic cells. Biochem Soc Trans. 1976;4(4):673–675. doi: 10.1042/bst0040673. [DOI] [PubMed] [Google Scholar]
  8. Sherbet G. V., Lakshmi M. S. The surface properties of some human intracranial tumour cell lines in relation to their malignancy. Oncology. 1974;29(4):335–347. doi: 10.1159/000224916. [DOI] [PubMed] [Google Scholar]
  9. Tormey D. C., Waalkes T. P., Simon R. M. Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophin. Cancer. 1977 Jun;39(6):2391–2396. doi: 10.1002/1097-0142(197706)39:6<2391::aid-cncr2820390613>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  10. Tormey D. C., Waalkes T. P., Snyder J. J., Simon R. M. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen. Cancer. 1977 Jun;39(6):2397–2404. doi: 10.1002/1097-0142(197706)39:6<2397::aid-cncr2820390614>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  11. Wang D. Y., Bulbrook R. A., Hayward J. L., Hendrick J. C., Franchimont P. Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer. Eur J Cancer. 1975 Sep;11(9):615–618. doi: 10.1016/0014-2964(75)90094-8. [DOI] [PubMed] [Google Scholar]
  12. Yogeeswaran G., Stein B. S., Sebastian H. Altered cell surface organization of gangliosides and sialylglycoproteins of mouse metastatic melanoma variant lines selected in vivo for enhanced lung implantation. Cancer Res. 1978 May;38(5):1336–1344. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES